entertainment -WSS

entertainment

author：entertainment 2025-09-28 15:21:05 - browse：56

The cost of healthcare health technology assessment — APStock

Physicians are in line to absorb more Medicare cuts next year, while hospital outpatient departments and surgery centers will get billions in new revenue.

The base figure that determines how much physicians get paid by Medicare will decrease by 3.3% for 2024, the federal government said Thursday.

The cuts will not be distributed equally among all specialties. Indeed, primary care doctors, endocrinologists, nurse practitioners, and physician assistants would see their Medicare payment rates rise, on average, according to the annual payment rule. Cuts would be steepest for all types of radiologists, including interventionalists and nuclear medicine, as well as vascular surgeons.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Microsoft's Peter Lee: Generative AI could help doctors be more human

focus

WSS

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

Families look for replacement for GSK asthma drug Flovent

Flagship Pioneering startup Sonata Therapeutics lays off 21

Why Talkspace is targeting Medicare, a tricky market

Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

Ozempic has benefits for kidney disease as well as diabetes

explore

entertainment

hotspot

Novavax promises a turnaround & Lilly roils the obesity market

Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead

Alkermes shareholders re

Streamlined flu vaccines recommended by FDA advisory panel

Heart attack and stroke risk calculators need revising

Surprise medical billing ban raises prices elsewhere

Moonlake's readout produced a cash windfall. Risks remain

$1 billion proposal to grow Boston, Massachusetts biotech

Cancer drug shortages should be causing more outrage

Florida health officials providing scant details on measles cases

hotspot

First over

Ukraine seeks to reclaim its role as a hub for clinical trials

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

Ukraine seeks to reclaim its role as a hub for clinical trials

Researchers tackle phage therapy hurdles for wider adoption

Abridge raises $150m as clinical notes automation market heats up

leisure time

focus

focus

hotspot